Home › Skin Cancer › NCT07222995

Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs

A Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in Federal Qualified Health Centers

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Be a patient of any race or ethnicity attending one of the six Tampa Family Health Centers.
* Be 18 years of age or older.
* Self-report skin cancer risk behaviors within the past 12 months, including: Intentional sun exposure (e.g., outdoor or indoor tanning) or unintentional sun exposure leading to sunburn.
* Be willing to complete a baseline questionnaire and provide a saliva sample for MC1R genotyping.
* Be able to provide informed consent (written or electronic).
* Prefer English or Spanish for communication and study materials.

Exclusion Criteria:

* Do not report any skin cancer risk behaviors (i.e., no tanning or sunburning in the past 12 months).
* Are unwilling or unable to complete the baseline assessment or return the saliva kit.
* Decline to provide informed consent.
* Are under 18 years of age.

About the study

The purpose of this study is to examine how different messages about risk of skin cancer can impact the uptake of skin cancer prevention activities.

What is being tested

• Precision Prevention Booklet (behavioral)
• Standard Prevention Booklet (behavioral)

Sponsor: H. Lee Moffitt Cancer Center and Research Institute · Participants: 2,900 · Started: Oct 10, 2025

Contact the study team

• Rania Abdulla · Phone: 813-745-6813

Official record on ClinicalTrials.gov — NCT07222995

Locations in the U.S.

Conditions

• Skin Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.